4th Quarter - Report

SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING for SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Firm
Client
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Energy/Nuclear ENG

Patient dosing issues with NRC's ACMUI.

LobbyistCovered position, as disclosed
WAYNE ALAN POWELL —

Contacted: HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); SENATE; Energy, Dept of; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Nuclear Regulatory Commission (NRC)

Health Issues HCR

Medicare coverage and reimbursement.

LobbyistCovered position, as disclosed
WAYNE ALAN POWELL —

Contacted: Nuclear Regulatory Commission (NRC); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Energy, Dept of; SENATE

Medicare/Medicaid MMM

Medicare coverage and reimbursement.

LobbyistCovered position, as disclosed
WAYNE ALAN POWELL —

Contacted: SENATE; Food & Drug Administration (FDA); Energy, Dept of; Nuclear Regulatory Commission (NRC); Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Compounding of radiopharmaceuticals.

LobbyistCovered position, as disclosed
WAYNE ALAN POWELL —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Energy, Dept of; Nuclear Regulatory Commission (NRC); SENATE; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.